TE BOEKHORST PAUL FRANCIS OLIVIER (President and CEO) purchased 81.8% of their position (8K shares) of IMMUCELL CORP /DE/ on the open market
Open‑market purchase worth $76.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/22/2026ACC: 0001437749-26-021258
DirectorOfficer· President and CEO
Since Jan 2026
+8K
Net shares
Net buyer
$76.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
8K acquired
Non-Derivative Transactions1
Common Stock, par value $.01 per share
Direct
Shares
+8K
Price / share
$9.49
Trade value
$75.96K
% of position
81.8%
6/18/2026
9.79K→17.79K
Total
Net shares
+8K
Net value
$75.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.01 per share Direct | 6/18/2026 | P · Purchase | +8K | $9.49 | $75.96K | 81.8% | 9.79K | 17.79K |
| Total | +8K | $75.96K | ||||||
Derivative Transactions0
No derivative transactions reported